// App-Quantinova.ai

TPS187 : PLATFORM: Planning treatment of oesophago-gastric (OG) cancer—A randomised maintenance therapy trial.

Researchers

Presenter

  • Catherine Cafferkey

Principal Investigators

  • Ian Chau

  • Fiona Thistlethwaite

  • Russell D. Petty

  • Naureen Starling

  • David Watkins

  • Sheela Rao

  • Claire Saffery

  • Bijal Patel

  • Clare Peckitt

  • David Cunningham

Medical Centers

  • King's College Hospital - London - United Kingdom of Great Britain & Northern Ireland

  • Royal Marsden Hospital, Surrey, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • University of Aberdeen, Aberdeen, UK

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Royal Marsden, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed death-ligand 1

  • erb-b2 receptor tyrosine kinase 2

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Capecitabine

  • Trastuzumab

  • Durvalumab

Outcome

  • N/A

Study Design

  • Randomized

  • Adaptive

  • Open Label

  • Multicenteric

  • Prospective

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved